RSS   Newsletter   Contact   Advertise with us
Post Online Media

Regulus names VP, investor relations & corporate communications

Allison WeyRegulus Therapeutics Inc., a biopharmaceutical company, announced that Allison Wey has been appointed vice president, investor relations and corporate communications.

Ms. Wey brings over 25 years of experience in investor relations, corporate communications, media relations and investment banking.

Article continues below

READ MORE Regulus elects Michael Huang as VP, clinical development

Prior to joining Regulus, Ms. Wey was Vice President, Investor Relations for Durata Therapeutics up until its acquisition by Actavis. Before Durata, Ms. Wey served as Vice President, Investor Relations and Corporate Affairs at Par Pharmaceuticals from 2007 until its acquisition by TPG.

Ms. Wey also has extensive experience in media relations and corporate communications including working as VP, Investor Relations at Boron, LePore & Associates, Senior VP at Edelman Financial Worldwide, Managing Director, Financial Communications at Hill & Knowlton, and Associate Director, Equity Capital Markets at Bear, Stearns & Co. Inc..

What to read next


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy